Biocompatibility and bioactivity of plasma-treated biodegradable poly(butylene succinate).
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 18760682.
- Also identified by DOI 10.1016/j.actbio.2008.07.017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Poly(butylene succinate) (PBSu), a novel biodegradable aliphatic polyester with excellent processability and mechanical properties, is a promising substance for bone and cartilage repair. However, it typically suffers from insufficient biocompatibility and bioactivity after implantation into the human body. In this work, H(2)O or NH(3) plasma immersion ion implantation (PIII) is conducted for the first time to modify the PBSu surface. Both the treated and control specimens are characterized by X-ray photoelectron spectroscopy, contact angle measurements and atomic force microscopy. The plasma treatments improve the hydrophilicity and roughness of PBSu significantly and the different PIII processes result in similar hydrophilicity and topography. C-OH and C-NH(2) functional groups emerge on the PBSu surface after H(2)O and NH(3) PIII, respectively. The biological results demonstrate that both osteoblast compatibility and apatite formability are enhanced after H(2)O and NH(3) PIII. Furthermore, our results suggest that H(2)O PIII is more effective in rendering PBSu suitable for bone-replacement implants compared to NH(3) PIII.
Medical subject headings
- Biocompatible Materials
- Butylene Glycols
- Polyenes
- Polymers
- Succinic Acid